In a recent corporate announcement, HEALTHYWAY INC (ASX: 02587) has disclosed a change to its board composition.
Mr. Zhang Xiangming has tendered his resignation as a non-executive director of the company, effective from June 10, 2026. His decision to step down is to allow him to dedicate more time to his personal affairs.
Concurrent with his resignation from the board, Mr. Zhang will also cease to serve as a member of the company's audit committee, remuneration committee, and nomination committee, with this change also taking effect on June 10, 2026.
Following this departure, the company has announced the appointment of Mr. Wang Junfeng as a non-executive director.
Mr. Wang's appointment to the board, which is also effective from June 10, 2026, includes concurrent membership on the audit committee, remuneration committee, and nomination committee.
Comments